Accumulation of HIV-1 Drug Resistance Mutations and Methamphetamine Use

Overview

Journal Curr HIV Res

Publisher Bentham Science Publishers

Date 2021 Jun 28

PMID 34176462

Authors

Hong-Ha M Truong

Robin Fatch

Steven G Deeks

Melissa Krone

Jeffrey N Martin

Peter W Hunt

Paula J Lum

Affiliations

Soon will be listed here.

Abstract

Background: Antiretroviral therapy (ART) non-adherence and methamphetamine use are associated with higher HIV drug resistance prevalence. How they affect drug resistance mutations accumulation is less studied.

Objective: We assessed factors associated with drug resistance mutations accumulation.

Methods: We evaluated HIV chronically-infected patients from a clinic-based research cohort on first-line ART regimens with genotype results within 30 days of baseline. Methamphetamine use and ART adherence were self-reported at each study visit. High ART adherence was defined as 0-5% missed doses in the last 30 days.

Results: One-hundred twenty-five patients contributed 496 study visits. At baseline, 81% of patients reported high ART adherence; 90% reported no methamphetamine use in the prior 4 months, 8% used monthly or less and 2% used daily or weekly. Methamphetamine users and non-users had similarly high ART adherence (p=0.93). Adjusted incidence rate ratio (aIRR) of drug resistance mutations accumulation was 2.04 (95% CI 0.64, 6.46) for daily/weekly users and 1.71 (95% CI 0.66, 4.42) for patients with monthly or less users, compared to non-users. aIRR was 0.71 (95% CI 0.44, 1.15) with >5-10% missed ART doses and 1.21 (95% CI 0.80, 1.83) with >10% missed doses compared to 0-5% missed doses.

Conclusion: We found no strong evidence for the effect of methamphetamine use and ART adherence on drug resistance mutations accumulation. Research cohort patients may have been more engaged in care and treatment adherent than non-cohort patients. Our findings suggest methamphetamine use might not lead to treatment failure among HIV patients who are otherwise engaged in care.

References

Ellis R, Childers M, Cherner M, Lazzaretto D, Letendre S, Grant I . Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003; 188(12):1820-6. DOI: 10.1086/379894. View

Reback C, Larkins S, Shoptaw S . Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care. 2003; 15(6):775-85. DOI: 10.1080/09540120310001618621. View

Truong H, Grant R, McFarland W, Kellogg T, Kent C, Louie B . Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS. 2006; 20(17):2193-7. DOI: 10.1097/01.aids.0000252059.85236.af. View

Vaudrey J, Raymond H, Chen S, Hecht J, Ahrens K, McFarland W . Indicators of use of methamphetamine and other substances among men who have sex with men, San Francisco, 2003-2006. Drug Alcohol Depend. 2007; 90(1):97-100. DOI: 10.1016/j.drugalcdep.2007.02.020. View

Carrico A, Hunt P, Neilands T, Dilworth S, Martin J, Deeks S . Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2018; 80(1):89-93. PMC: 6289664. DOI: 10.1097/QAI.0000000000001867. View

Cachay E, Moini N, Kosakovsky Pond S, Pesano R, Lie Y, Aiem H . Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration. Open AIDS J. 2008; 1:5-10. PMC: 2556194. DOI: 10.2174/1874613600701010005. View

Gorbach P, Drumright L, Javanbakht M, Pond S, Woelk C, Daar E . Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr. 2008; 47(5):639-43. PMC: 4153748. DOI: 10.1097/QAI.0b013e3181684c3d. View

Deeks S, Hecht F, Swanson M, Elbeik T, Loftus R, Cohen P . HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS. 1999; 13(6):F35-43. DOI: 10.1097/00002030-199904160-00001. View

Carrico A, Riley E, Johnson M, Charlebois E, Neilands T, Remien R . Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. J Acquir Immune Defic Syndr. 2010; 56(2):146-50. PMC: 3494991. DOI: 10.1097/QAI.0b013e318201df63. View

10.

Tucker J, Burnam M, Sherbourne C, Kung F, Gifford A . Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003; 114(7):573-80. DOI: 10.1016/s0002-9343(03)00093-7. View

11.

Parsons J, Kowalczyk W, Botsko M, Tomassilli J, Golub S . Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS Behav. 2013; 17(4):1478-87. PMC: 3643207. DOI: 10.1007/s10461-013-0463-7. View

12.

Sanchez T, Zlotorzynska M, Craig Sineath R, Kahle E, Tregear S, Sullivan P . National Trends in Sexual Behavior, Substance Use and HIV Testing Among United States Men Who have Sex with Men Recruited Online, 2013 Through 2017. AIDS Behav. 2018; 22(8):2413-2425. DOI: 10.1007/s10461-018-2168-4. View

13.

Marquez C, Mitchell S, Hare C, John M, Klausner J . Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care. 2009; 21(5):575-82. DOI: 10.1080/09540120802385579. View

14.

Schwarcz S, Scheer S, McFarland W, Katz M, Valleroy L, Chen S . Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health. 2007; 97(6):1067-75. PMC: 1874212. DOI: 10.2105/AJPH.2005.072249. View

15.

Grant R, Hecht F, Warmerdam M, Liu L, Liegler T, Petropoulos C . Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002; 288(2):181-8. DOI: 10.1001/jama.288.2.181. View

16.

Zlotorzynska M, Cantu C, Rai R, Sullivan P, Sanchez T . The Annual American Men's Internet Survey of Behaviors of Men Who Have Sex With Men in the United States: 2017 Key Indicators Report. JMIR Public Health Surveill. 2020; 6(2):e16847. PMC: 7186873. DOI: 10.2196/16847. View

17.

Rajasingham R, Mimiaga M, White J, Pinkston M, Baden R, Mitty J . A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine. AIDS Patient Care STDS. 2011; 26(1):36-52. PMC: 3248609. DOI: 10.1089/apc.2011.0153. View

18.

Hinkin C, Barclay T, Castellon S, Levine A, Durvasula R, Marion S . Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2006; 11(2):185-94. PMC: 2867605. DOI: 10.1007/s10461-006-9152-0. View

19.

Truong H, Kellogg T, McFarland W, Louie B, Klausner J, Philip S . Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection. PLoS One. 2011; 6(10):e25281. PMC: 3189011. DOI: 10.1371/journal.pone.0025281. View

20.

Colfax G, Vittinghoff E, Grant R, Lum P, Spotts G, Hecht F . Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS. 2007; 21(2):239-41. DOI: 10.1097/QAD.0b013e3280114a29. View